Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2026-07-01 16:35:15 ET · period of report 2026-06-30 · accession 0001468308-26-000024 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-01 16:35 | 2026-06-30 | FENC | Andrade Robert | CFO | A - Grant | $0.00 | +1,703 | 291.0K | +0.6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2026-06-30 | A | A | 1,703 | $0.00 | 290,972 | D | — | — | (F1) Represents shares released from restriction from shares awarded 5/16/2024 and 3/28/2025. |